Search
for
Sort by
Research 181–210 of 571
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- BPH Medications May Increase Risk of Self-Harm, Depression
- [Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data].
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Causes of hair loss and the developments in hair rejuvenation
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Sex-Chromosome-Related Dimorphism in Steroidogenic Enzymes and Androgen Receptor in Response to Testosterone Treatment: An In Vitro Study on Human Primary Skeletal Muscle Cells
- Hair loss improvement effect of Chrysanthemum zawadskii, peppermint and Glycyrrhiza glabra herbal mixture in human follicle dermal papilla cell and C57BL/6 mice
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- Effect of Coffee Berry Extract on Anti-Aging for Skin and Hair—In Vitro Approach
- Impact of Microbial Infection on Sperm Parameters of Seminal Bacteria in Asymptomatic Subfertile Males
- Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
- Possible Role of Osteopathic Manipulation Treatment in Alleviation of Finasteride-Induced Dementia through Modulation of HOMER-3 Gene Methylation
- Study on the Efficacy and Potential Mechanism of Topical Shen Bai Hair Growing Decoction against Androgenetic Alopecia Based on Ultrahigh Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry and RNA-seq
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus
- Efficacy of Dutasteride Intradermal Injection in The Treatment of Androgenetic Alopecia
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Finasteride in Frontal Fibrosing Alopecia: Joining the Dots!
- Association between Insulin Resistance and Hyperandrogenism among Women with PCOS in Pakistan
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- No increased risk of CV events with dutasteride vs finasteride
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Evaluation and treatment of male and female pattern hair loss